# The Potential of Optical Coherence Tomography Angiography (OCTA) to Detect Early Cognitive Dysfunction in Diabetic Patients

> **NCT07135440** · — · ACTIVE_NOT_RECRUITING · sponsor: **Dr. Sefic Eye Polylcinic and Optical Studio** · enrollment: 210 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus Diabetic Retinopathy Cognitive Dysfunction

## Interventions

- **DEVICE:** OCT angiography RTVue XR Avanti; Optovue, Inc, Fremont, California, USA

## Key facts

- **NCT ID:** NCT07135440
- **Lead sponsor:** Dr. Sefic Eye Polylcinic and Optical Studio
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-11-01
- **Primary completion:** 2025-10-30
- **Final completion:** 2025-12-31
- **Target enrollment:** 210 (ESTIMATED)
- **Last updated:** 2025-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07135440

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07135440, "The Potential of Optical Coherence Tomography Angiography (OCTA) to Detect Early Cognitive Dysfunction in Diabetic Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07135440. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*